Hemostasis Valve Market Size, Share & Trends Analysis Report By Type, By Application (Angiography, Angioplasty), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Hemostasis Valve Market Size & Trends
The global hemostasis valve market size was estimated at USD 174.8 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. According to the report published by World Heart Federation in 2023, cardiovascular diseases (CVDs) have a profound global impact, affecting over half a billion people worldwide and resulting in approximately 20.5 million deaths in 2021.This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.
The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. The shift towards minimally invasive techniques in cardiology and other medical fields drives the adoption of hemostasis valves.
The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.
Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medi
cal interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.
Global Hemostasis Valve Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and regions.
- Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemostasis Valve Y- Connectors
- Double Y- Connector Hemostasis Valves
- One- Handed Hemostasis Valves
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Angiography
- Angioplasty
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application Outlook
- 2.2.3. End Use Outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Hemostasis Valve Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Industry Analysis – Porter’s
- 3.2.3.1. Bargaining power of the suppliers
- 3.2.3.2. Bargaining power of the buyers
- 3.2.3.3. Threats of substitution
- 3.2.3.4. Threats from new entrants
- 3.2.3.5. Competitive rivalry
- 3.2.4. PESTEL Analysis
- 3.2.4.1. Political landscape
- 3.2.4.2. Economic and Social landscape
- 3.2.4.3. Technological landscape
- 3.3. Impact of COVID-19 on the Hemostasis Valve Market
- 3.4. Pricing Analysis
- Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Hemostasis Valve Market: Type Movement Analysis, 2023 & 2030 (USD Million)
- 4.2.1. Hemostasis Valve Y- Connectors
- 4.2.1.1. Hemostasis Valve Y- Connectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Double Y – Connector Hemostasis Valves
- 4.2.2.1. Double Y – Connector Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.3. One-Handed Hemostasis Valves
- 4.2.3.1. One-Handed Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.4. Others
- 4.2.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Hemostasis Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 5.2.1. Angiography
- 5.2.1.1. Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Angioplasty
- 5.2.2.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.2.3. Angioplasty
- 5.2.3.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Hemostasis Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 6.2.1. Hospitals
- 6.2.1.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Ambulatory Surgical Centers
- 6.2.2.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Others
- 6.2.3.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework/ reimbursement structure
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework/ reimbursement structure
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework/ reimbursement structure
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework/ reimbursement structure
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework/ reimbursement structure
- 7.7.6.3. Competitive scenario
- 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework/ reimbursement structure
- 7.8.1.3. Competitive scenario
- 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework/ reimbursement structure
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Regulatory framework/ reimbursement structure
- 7.9.1.3. Competitive scenario
- 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework/ reimbursement structure
- 7.9.2.3. Competitive scenario
- 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework/ reimbursement structure
- 7.9.3.3. Competitive scenario
- 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework/ reimbursement structure
- 7.9.4.3. Competitive scenario
- 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. Key company market share analysis, 2023
- 8.3.2. Boston Scientific Corporation
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Type benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Teleflex Incorporated
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Type benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Merit Medical Systems
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Type benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. B. Braun Melsungen AG
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Type benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. TERUMO CORPORATION
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Type benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Abbott
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Type benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Argon Medical Devices
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Type benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Freudenberg Medical
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Type benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. SCW Medicath Ltd
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Type benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Lepu Medical Technology (Beijing)Co.,Ltd.
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Type benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Nipro
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Type benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. DeRoyal Industries, Inc.
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Type benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Antmed Corporation
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Type benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. Beijing Demax Medical Technology Co
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Type benchmarking
- 8.3.15.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook